Back to top
more

Labcorp Holdings Inc. (LH)

(Delayed Data from NYSE)

$265.85 USD

265.85
548,487

+5.89 (2.27%)

Updated Aug 8, 2025 04:00 PM ET

After-Market: $266.03 +0.18 (0.07%) 5:42 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value A Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (97 out of 244)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

LabCorp (LH) Stock Moves -0.4%: What You Should Know

by Zacks Equity Research

LabCorp (LH) closed the most recent trading day at $265.73, moving -0.4% from the previous trading session.

Sanghamitra Saha headshot

5 Top-Ranked Stocks Likely to Beat Earnings Estimates

by Sanghamitra Saha

These top-ranked stocks are likely to beat on the bottom line in their next releases.

Zacks Equity Research

This 1 Medical Stock Could Beat Earnings: Why It Should Be on Your Radar

by Zacks Equity Research

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

Zacks Equity Research

Rise in COVID Tests to Boost Thermo Fisher (TMO) Q4 Earnings

by Zacks Equity Research

With the emergence of the Omicron variant through the Q4 months globally, Thermo Fisher's (TMO) Life-Science Solutions segment is likely to have registered strong top-line contributions.

Zacks Equity Research

Boston Scientific (BSX) Hit by Procedure Deferrals Amid COVID

by Zacks Equity Research

Although Boston Scientific (BSX) reports margin expansion on a year-over-year basis, the decline in R&D expenses is concerning.

Zacks Equity Research

Here's Why You Should Add LabCorp (LH) to Your Portfolio Now

by Zacks Equity Research

Investors are optimistic about LabCorp (LH) backed by increased COVID-19 testing demand and development in high-growth areas.

Zacks Equity Research

LabCorp (LH) Gains As Market Dips: What You Should Know

by Zacks Equity Research

LabCorp (LH) closed at $271.57 in the latest trading session, marking a +0.26% move from the prior day.

Zacks Equity Research

Rise in COVID-19 Test Demand to Boost Abbott (ABT) Q4 Earnings

by Zacks Equity Research

With the latest surge in COVID infections due to the more contagious Omicron variant, Abbott (ABT) is expected to report sequentially stronger diagnostics results for the fourth quarter.

Zacks Equity Research

Walgreens (WBA), Village MD Plan to Expand Into Arizona

by Zacks Equity Research

Walgreens (WBA) and VillageMD to improve access to overall care for patients with chronic conditions by opening eight new Village Medical at Walgreens primary care practices in the Tucson area.

Zacks Equity Research

LabCorp (LH) Stock Moves -0.42%: What You Should Know

by Zacks Equity Research

LabCorp (LH) closed the most recent trading day at $270.87, moving -0.42% from the previous trading session.

Zacks Equity Research

Zimmer Biomet's (ZBH) Pandemic Recovery Slow, Margin Woes Stay

by Zacks Equity Research

The third quarter brings greater COVID-related pressure than expected for Zimmer Biomet (ZBH).

Zacks Equity Research

Here's Why You Should Retain STERIS (STE) Stock for Now

by Zacks Equity Research

Investors are optimistic about STERIS' (STE) strong segmental performance and bullish 2022 outlook.

Zacks Equity Research

Edwards Lifesciences (EW) to Post Q4 Earnings: What's in Store?

by Zacks Equity Research

Improvement in TAVR and TMTT businesses is expected to have contributed to Edwards Lifesciences' (EW) fourth-quarter results.

Zacks Equity Research

Here's Why You Should Retain Change Healthcare (CHNG) Stock

by Zacks Equity Research

Change Healthcare (CHNG) continues to benefit from a robust payment accuracy business. However, intense competition remains a woe.

Zacks Equity Research

Here's Why You Should Hold on to PerkinElmer (PKI) Stock Now

by Zacks Equity Research

PerkinElmer (PKI) continues to gain momentum from a solid product portfolio and healthy margins. However, forex woes linger.

Zacks Equity Research

DaVita's (DVA) New Buyout to Enhance Transplant Experience

by Zacks Equity Research

DaVita (DVA) acquires MedSleuth which will help simplify the kidney transplant process and provide patients greater access to transplantation.

Zacks Equity Research

Here's Why You Should Hold SmileDirectClub (SDC) Stock for Now

by Zacks Equity Research

Investors are optimistic about SmileDirectClub (SDC), backed by its expansion in the teledentistry space and the long-term growth target.

Zacks Equity Research

Alcon's (ALC) Global Growth Solid, New Lenses Sales Rise

by Zacks Equity Research

Alcon's (ALC) new contact lenses are gaining market share and the Systane brand family has been posting strong double-digit growth in all regions.

Zacks Equity Research

Quest Diagnostics (DGX) Expands Extended Care With New Buyout

by Zacks Equity Research

This latest acquisition builds on Quest Diagnostics' (DGX) 2018 acquisition of Mobile Medical Examination Service (MedXM), a provider of home-based health risk assessments and related services.

Zacks Equity Research

Abbott's (ABT) Organic Base Sales Grow Amid COVID Case Surge

by Zacks Equity Research

Even though COVID-19 case rates are surging, Abbott (ABT) is registering growth in its more consumer-facing businesses like nutrition, established pharmaceuticals and diabetes care.

Zacks Equity Research

Inari Medical (NARI) Posts Solid Preliminary Q4, FY2021 Revenues

by Zacks Equity Research

Inari Medical (NARI) posts solid fourth-quarter and full-year 2021 revenue data, courtesy of resilience shown in the face of the COVID-19 induced challenges.

Urmimala Biswas headshot

5 Lucrative PEG Stocks for Value Investors

by Urmimala Biswas

Here are five value stocks, ACI, LH, PSX, FDX and SWRAY, matching our criteria.

Zacks Equity Research

QIAGEN (QGEN) to Boost Testing Capacity With Liquid-Based Kit

by Zacks Equity Research

QIAGEN's (QGEN) artus SARS-CoV-2 Prep&Amp UM is faster than standard processes and can spot the virus more reliably, including the new Omicron variant.

Zacks Equity Research

IDEXX (IDXX) Collaborates With PetDx for Canine Cancer Test

by Zacks Equity Research

Following the partnership between IDEXX (IDXX) and PetDx , the test is likely to be available later in January to all veterinary customers of IDXX in the United States and Canada.

Zacks Equity Research

Intuitive Surgical (ISRG) Posts Robust Preliminary Q4 Results

by Zacks Equity Research

Intuitive Surgical (ISRG) posts solid fourth-quarter and full-year 2021 results driven primarily by da Vinci procedure volume growth.